China’s State Administration for Market Regulation has approved the proposed acquisition of Hologic Inc by private equity firms Blackstone Inc and TPG Inc, according to a report by Reuters.
The regulator did not specify whether the approval relates to particular China-based units of Hologic, which develops medical imaging and diagnostic technologies focused on women’s health, and maintains manufacturing operations and partnerships in the country.
Blackstone and TPG announced in October that they had agreed to take Hologic private in a transaction valued at $18.3bn, including debt, marking the largest medical devices buyout in nearly two decades.
